Inventiva S.A. (NASDAQ:IVA) Q4 2025 Earnings Call Transcript March 31, 2026 Operator: Good day, and thank you for standing by. Welcome to the Inventiva Full Year 2025 Financial Report Webcast and ...
The first deep field image captured by the James Webb Space Telescope is of galaxy cluster SMACS 0723. Credit: NASA, ESA, CSA ...
Cash and cash equivalents totaled €101.1 million as of December 31, 2025Revenues amounting to €65.4 million for the ...
GENFIT’s 2025 Universal Registration Document includes, in particular: The Statutory Auditors’ reports on the annual and consolidated financial statements and related-party agreements, The table ...
During the event, ProQR provided an overview of its RNA editing pipeline and development strategy, emphasizing its lead clinical program AX-0810, expansion of its pipeline with two new programs ...
Mount Rushmore may have its home in South Dakota, but it’s also in Shenzhen, China. Here, the four presidents stare out over ...
For Madam Samaai, 69, every breath is a struggle, reflecting a growing burden of chronic respiratory diseases across Africa ...
Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...
Cash and cash equivalents totaled €101.1 million as of December 31, 2025Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million ...
PBMs have launched clinical programs pairing GLP-1 prescriptions with pharmacist coaching, nutrition support, behavioral ...
At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2025, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results